Long-term safety, efficacy, and patient acceptability of teriparatide in the management of glucocorticoid-induced osteoporosis.

Patient Prefer Adherence · 2013 · PMC3663438 · PMID 23717037

Europe PMC DOI

hedged sentence

0.0740

closest p · 1.5× alpha

0.0740

boldest claim

The sentences

did not reach statistical significanceP = 0.074so close (0.05 < p ≤ 0.1)

There was a trend for higher bone volume/trabecular volume in the teriparatide-treated subjects, but this did not reach statistical significance (23.1% versus 7.3%, P = 0.074).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.